华仁药业 (300110.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

主营构成(按产品)(华仁药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2024年年报2024年中报2023年年报2023年中报
营业收入(元)
 基础输液(元) 253,474,124.76680,664,345.50414,546,403.90818,826,786.72418,097,884.86
 医疗器械(元) 50,773,812.54-62,950,939.34-87,110,865.15
 治疗制剂(元) 93,115,418.37170,797,983.59103,133,000.79165,373,883.7488,272,293.08
 腹透液(元) 217,731,967.46348,122,524.90178,126,326.09340,242,864.63159,123,185.82
 其他(元) 8,801,111.32153,576,964.0612,704,550.47311,812,821.7076,442,080.59
营业成本(元)
 基础输液(元) 154,499,285.62458,060,560.18252,228,336.22474,227,333.40233,483,449.84
 医疗器械(元) 45,125,721.09-49,258,216.70-75,644,752.66
 治疗制剂(元) 48,043,142.3588,470,949.9548,836,091.9957,589,583.6228,923,163.69
 腹透液(元) 134,880,351.57211,541,076.96121,982,931.72198,208,616.7092,736,590.99
 其他(元) 5,932,627.96118,754,812.187,891,927.09207,176,444.8348,636,988.55
毛利(元)
 基础输液(元) 98,974,839.14222,603,785.32162,318,067.68344,599,453.32184,614,435.02
 医疗器械(元) 5,648,091.45-13,692,722.64-11,466,112.49
 治疗制剂(元) 45,072,276.0282,327,033.6454,296,908.80107,784,300.1259,349,129.39
 腹透液(元) 82,851,615.89136,581,447.9456,143,394.37142,034,247.9366,386,594.83
 其他(元) 2,868,483.3634,822,151.884,812,623.38104,636,376.8727,805,092.04
毛利率(%)
 基础输液(%) 39.0532.7039.1642.0844.16
 医疗器械(%) 11.12-21.75-13.16
 治疗制剂(%) 48.4048.2052.6565.1867.23
 腹透液(%) 38.0539.2331.5241.7441.72
 其他(%) 32.5922.6737.8833.5636.37
收入构成(%)
 基础输液(%) 40.6350.3053.7450.0450.43
 医疗器械(%) 8.14-8.16-10.51
 治疗制剂(%) 14.9212.6213.3710.1110.65
 腹透液(%) 34.9025.7323.0920.7919.19
 其他(%) 1.4111.351.6519.069.22
毛利构成(%)
 基础输液(%) 42.0446.7355.7349.3052.80
 医疗器械(%) 2.40-4.70-3.28
 治疗制剂(%) 19.1517.2818.6415.4216.98
 腹透液(%) 35.1928.6719.2820.3218.99
 其他(%) 1.227.311.6514.977.95

前瞻产业研究院